enCompass Carolina: A Social Support and Coaching Program for Cancer Caregivers
1 other identifier
interventional
111
1 country
1
Brief Summary
This study explores the feasibility, acceptability, and preliminary efficacy of a social support intervention in cancer caregivers who live in rural communities. Cancer caregivers need support, especially when they live at a distance from healthcare centers. enCompass Carolina is a social support intervention, that supports caregivers by helping them find and use new sources of support. The purpose of this study is to test and receive feedback about the program.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable cancer
Started May 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 12, 2023
CompletedFirst Posted
Study publicly available on registry
April 25, 2023
CompletedStudy Start
First participant enrolled
May 15, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 24, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 24, 2024
CompletedMarch 30, 2025
March 1, 2025
1.1 years
April 12, 2023
March 25, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Study feasibility - caregiver enrollment
Study feasibility will be measured by caregiver enrollment rates, defined as the proportion of eligible caregivers approached about the study who consent to participate.
8 weeks
Study feasibility - Caregiver intervention engagement
Study feasibility will be measured by caregiver intervention engagement, defined as the proportion of enrolled caregiver subjects who receive at least one intervention visit.
8 weeks
Secondary Outcomes (3)
Intervention acceptability-qualitative
4 weeks, 8 weeks
Intervention acceptability-quantitative
4 weeks, 8 weeks
Caregiver self-efficacy
Baseline, 4 weeks, 8 weeks
Study Arms (2)
Caregiver of subject with cancer
OTHERAdults who identify as a primary unpaid caregiver for a rural-dwelling adult with cancer.
Subject with Cancer
NO INTERVENTIONSubjects is with cancer and receive care from caregivers.
Interventions
The web application allows caregivers to visually identify and organize their existing social network (family, friends, community of worship, and others) to assist with their support needs, tailored to their context. For each of the six support social support domains (in-home, informational, communication, financial, emotional and spiritual, transportation (e.g., emotional, informational, practical), the enCompass web application prompts the individual to identify members of their network. After completing each domain, caregivers are presented with a visual social support
Caregivers engage in up to 8 manualized, telephone/videoconference visits with a trained caregiver coach. The caregiver coach uses the study manual and interview guide to provide support for caregiver support-seeking and problem-solving.
Eligibility Criteria
You may qualify if:
- English-speaking.
- Ability to provide written or electronic informed consent to participate in the study.
- Subject is willing and able to comply with study procedures based on the judgment of the investigator or protocol designee.
- Age ≥ 18 years at the time of consent. Identify as an informal (unpaid) caregiver for a rural-dwelling adult with a stage II-IV solid tumor or any hematologic malignancy in active treatment (see eligibility criteria for patients).
- Their identified caregiver is enrolled in the study
- English-speaking.
- Ability to provide written or electronic informed consent to participate in the study.
- Subjects are willing and able to comply with study procedures based on the judgment of the investigator or protocol designee.
- Age ≥ 18 years at the time of consent. Have a diagnosis of stage II-IV solid tumor or any hematologic malignancy receiving active treatment s, not including hormonal therapy
- \. Live in a rural area according to the USDA's Rural/Urban Commuting Area (RUCA) score of \>4.
You may not qualify if:
- Unable to complete self-report instruments due to illiteracy, neurologic illness, inability to speak or read English, or other causes;
- Existence of another co-morbid disease, which in the opinion of the investigator, prohibits participation in the protocol;
- Participation in the intervention development phase of this intervention.
- Unable to complete self-report instruments due to illiteracy, neurologic illness, inability to speak or read English, or other causes;
- Existence of another co-morbid disease, which in the opinion of the investigator, prohibits participation in the protocol;
- Their caregiver does not enroll in the study or withdraws consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- UNC Lineberger Comprehensive Cancer Centerlead
- The Duke Endowmentcollaborator
Study Sites (1)
UNC Lineberger
Chapel Hill, North Carolina, 27514, United States
Related Publications (1)
Kent EE, Tan KR, Nakamura ZM, Kovacs J, Gellin M, Deal A, Park EM, Reblin M. Building on and tailoring to: Adapting a cancer caregiver psychoeducational intervention for rural settings. Cancer Med. 2024 Sep;13(17):e70187. doi: 10.1002/cam4.70187.
PMID: 39234997DERIVED
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Erin E Kent, PhD, MS
Department of Health Policy and Management Gillings School of Global Public Health
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 12, 2023
First Posted
April 25, 2023
Study Start
May 15, 2023
Primary Completion
June 24, 2024
Study Completion
June 24, 2024
Last Updated
March 30, 2025
Record last verified: 2025-03